The objective of the proposed research is to identify and further characterize the biochemical and physiologic pathways that are responsible for the inflammation associated with urticaria, angioedema, late phase cutaneous reactions, and atopic and contact dermatitis. We will also characterize the immune response and inflammatory mechanisms of Lyme disease. We will determine the mechanism of bradykinin degradation in human plasma, develop assays for the degradation products, and purify and characterize the responsible enzymes. We will also purify and characterize histamine releasing factors (HRF) derived from human mononuclear cells. We will do c-DNA and/or genomic cloning of the factor(s) and therefore determine its amino acid sequence. We will develop functional and immunologic assays for HRF and apply them to the aforementioned disorders. We will also continue studies of mediator release in vitro and in vivo in various types of physically induced hives, hereditary and non-hereditary angioedema, and chronic urticaria. Emphasis will be placed on definitively identifying and type of kinin responsible for the swelling of hereditary angioedema, and the possible role of HRF in late phase cutaneous reactions, contact dermatitis, atopic dermatitis, and chronic urticaria. Finally, we will continue studies of Lyme disease, a common endemic disorder on Long Island and identify the antigens to which immune responses are directed, determine the nature of the immune response, and the mediator pathways responsible for tissue inflammation.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center (P50)
Project #
Application #
Study Section
Allergy, Immunology, and Transplantation Research Committee (AITC)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
State University New York Stony Brook
Schools of Medicine
Stony Brook
United States
Zip Code
O'Riordan, T G; Palmer, L B; Smaldone, G C (1994) Aerosol deposition in mechanically ventilated patients. Optimizing nebulizer delivery. Am J Respir Crit Care Med 149:214-9
Smaldone, G C; Foster, W M; O'Riordan, T G et al. (1993) Regional impairment of mucociliary clearance in chronic obstructive pulmonary disease. Chest 103:1390-6
O'Riordan, T G; Walser, L; Smaldone, G C (1993) Changing patterns of aerosol deposition during methacholine bronchoprovocation. Chest 103:1385-9
O'Riordan, T G; Zwang, J; Smaldone, G C (1992) Mucociliary clearance in adult asthma. Am Rev Respir Dis 146:598-603
O'Riordan, T G; Greco, M J; Perry, R J et al. (1992) Nebulizer function during mechanical ventilation. Am Rev Respir Dis 145:1117-22
Atkins, P C; Kaplan, A P; von Allmen, C et al. (1992) Activation of the coagulation pathway during ongoing allergic cutaneous reactions in humans. J Allergy Clin Immunol 89:552-9
Messina, M S; O'Riordan, T G; Smaldone, G C (1991) Changes in mucociliary clearance during acute exacerbations of asthma. Am Rev Respir Dis 143:993-7
Aug, C; Perry, R J; Smaldone, G C (1991) Technetium 99m radiolabeling of aerosolized drug particles from metered dose inhalers. J Aerosol Med 4:127-38
Jiang, W; Luft, B J; Munoz, P et al. (1990) Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi. J Immunol 144:284-9
Luft, B J; Jiang, W; Munoz, P et al. (1989) Biochemical and immunological characterization of the surface proteins of Borrelia burgdorferi. Infect Immun 57:3637-45

Showing the most recent 10 out of 29 publications